StockData
bioAffinity Technologies, Inc. logo

bioAffinity Technologies, Inc. (BIAF) stock

BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$2.15+0.22 (+11.40%)

Close on Nov 18, 2026Market cap $17.42MP/E –Yield –

bioAffinity Technologies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

bioAffinity Technologies's price to sales ratio was 0.2× on Nov 11, 2026, against 0.8× a year earlier. Over the last 4 years it ranged from 0.2× to 9.1×, with a median of 1.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.4
2025Dec 31, 20250.6×−0.7
2024Dec 31, 20241.3×−0.2
2023Dec 29, 20231.5×–

More bioAffinity Technologies figures

See a number that looks wrong?